| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/14/1998 | EP0817635A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | EP0533865B1 Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them |
| 01/13/1998 | US5708173 Heterocyclic compounds |
| 01/13/1998 | US5708171 Imidazole derivatives for pharmaceutical use |
| 01/13/1998 | US5708163 Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
| 01/13/1998 | US5708157 Secreted proteins and polynucleotides encoding them |
| 01/13/1998 | US5708149 Method for producing purified recombinant Haemophilus influenzae transferrin binding proteins |
| 01/13/1998 | US5708145 Antibodies |
| 01/13/1998 | US5708028 Use of Cis-9-heptadecenoic acid for treating psoriasis and allergies |
| 01/13/1998 | US5708023 Nonirritating gel for skin |
| 01/13/1998 | US5708020 Arylalkyl(thio)amides |
| 01/13/1998 | US5708016 Pseudopeptides derived from neurokinins |
| 01/13/1998 | US5708010 Methods of inhibiting myeloperoxidase activity |
| 01/13/1998 | US5708009 Methods of inhibiting myeloperoxidase activity |
| 01/13/1998 | US5708000 N4-substituted cytosinyl 1,3-oxathiolane nucleoside analogues, and their antiviral activity |
| 01/13/1998 | US5707989 Pyrimido 5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/12/1998 | CA2210056A1 Cyclic sulfone derivatives |
| 01/08/1998 | WO1998000439A2 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/08/1998 | WO1998000178A1 Aqueous-based pharmaceutical composition |
| 01/08/1998 | WO1998000168A1 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| 01/08/1998 | WO1998000145A1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 01/08/1998 | DE19632349C1 Verfahren zur Bestimmung von Eigenschaftsänderungen einer Probe Method for determining changes in the properties of a sample |
| 01/08/1998 | DE19624704A1 Neue Pyridylalkansäureamide New Pyridylalkansäureamide |
| 01/08/1998 | DE19624659A1 Neue Pyridylalken- und Pyridylalkinsäureamide New pyridylalkene and pyridylalkine acid |
| 01/08/1998 | DE19624154A1 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung Ring Anne lined dihydropyrans, methods of preparation and their use |
| 01/08/1998 | CA2258513A1 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| 01/08/1998 | CA2258038A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816357A1 Substituted indazole derivatives |
| 01/07/1998 | EP0815860A2 Terfenadine carboxylate and the treatment of allergic disorders |
| 01/07/1998 | EP0815856A2 Retroviral protease inhibitors |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815232A1 Protein production and delivery |
| 01/07/1998 | EP0815216A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 01/07/1998 | EP0815199A1 Human deoxycytidine kinase 2 |
| 01/07/1998 | EP0815133A1 Human stat4 |
| 01/07/1998 | EP0815132A1 Leptospiral outer membrane proteins |
| 01/07/1998 | EP0815127A1 Fucopeptides |
| 01/07/1998 | EP0815123A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
| 01/07/1998 | EP0814836A1 Vaccine adjuvants |
| 01/07/1998 | EP0814832A1 ISOFORMS OF HUMAN INTERLEUKIN-1$g(b) CONVERTING ENZYME AND METHODS OF USING THE SAME |
| 01/07/1998 | EP0814831A1 Method for treatment of autoimmune diseases using interferon-tau |
| 01/07/1998 | EP0814828A1 Method of preparation a therapeutic agent for the regeneration of oligodendrocytes |
| 01/07/1998 | EP0814821A1 Immunomodulating compositions from bile for the treatment of immune system disorders |
| 01/07/1998 | EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/07/1998 | EP0814812A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 01/07/1998 | EP0814809A1 Aryl thioxanthines |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814776A1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 01/07/1998 | EP0778847A4 Immunostimulatory agents |
| 01/07/1998 | EP0700301A4 Peptides and compounds that bind to elam-1 |
| 01/07/1998 | EP0669909B1 Substituted amidino compounds, their manufacture and methods of treatment |
| 01/07/1998 | EP0613458B1 Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/07/1998 | EP0542795B1 Tnf inhibitors |
| 01/07/1998 | CN1169722A 5-lipoxygenase inhibitors |
| 01/07/1998 | CN1169309A Compounded Chinese medicinal preparation containing ginseng and American ginseng and preparation method thereof |
| 01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705608 Polypeptides with dna sequence codes |
| 01/06/1998 | US5705504 Platelet activating factor |
| 01/06/1998 | US5705499 Viricides |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705389 Oligonucleotides that inhibit production of α-tumor necrosis factor |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 01/06/1998 | US5705159 Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049817A1 Brain glycogen phosphorylase cancer antigen |
| 12/31/1997 | WO1997049680A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049416A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | WO1997049286A1 Il-8 receptor antagonists |
| 12/31/1997 | CN1169161A Attenuated viruses and method of making same |
| 12/31/1997 | CA2258850A1 Il-8 receptor antagonists |
| 12/31/1997 | CA2258564A1 Brain glycogen phosphorylase cancer antigen |
| 12/31/1997 | CA2258168A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/30/1997 | USRE35706 Administering as viricides and antitumor agents |
| 12/30/1997 | US5703098 Inhibitors of cytokines including tumor necrosis factor |
| 12/30/1997 | US5703082 Enantiomers of 1- (4-chlorophenyl)phenylmethyl!- (4-methylphenyl)sulfonyl!pi |
| 12/30/1997 | US5703069 Method for inhibiting and controlling viral growth |
| 12/30/1997 | US5703058 Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
| 12/30/1997 | US5703057 Expression library immunization |
| 12/30/1997 | US5702698 Promoting production of colony stimulating factor |
| 12/30/1997 | CA2021529C N,n'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamides, preparation and their use |
| 12/30/1997 | CA1339609C 2-substituted-4-substituted-1, 3-dioxolanes, synthesis and use thereof |
| 12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |
| 12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
| 12/29/1997 | EP0813876A1 Cyclosporin-containing soft capsule preparations |
| 12/29/1997 | EP0813868A2 Retroviral protease inhibitors |
| 12/29/1997 | EP0813867A2 Retroviral protease inhibitors |
| 12/29/1997 | EP0813539A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 12/29/1997 | EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 12/29/1997 | EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/29/1997 | EP0813422A1 Compositions and methods for stimulating antibody class switching |